Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients
Launched by TANTA UNIVERSITY · Feb 13, 2025
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
The progressive deterioration of liver tissue over time is a hallmark of chronic liver disorders (CLD). Liver diseases are linked to a number of risk factors, including environmental pollutants, genetics, and infectious diseases. The process of liver damage may be accelerated when multiple factors work together.
Due to their involvement in numerous metabolic pathways, trace elements are essential for preserving health. The liver plays a crucial role in controlling the metabolic pathway and transport, tissue distribution, toxicity, and trace element bioavailability. Certain metabolic illnes...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic liver disease diagnosed by physical examination, laboratory investigations, and imaging study.
- Exclusion Criteria:
- • 1. Patients with Wilson disease.
- • 2. Patients with chronic renal diseases.
- • 3. Patients with IBD or any other cause of chronic diarrhea.
- • 4. Drugs affecting levels of trace elements e.g. corticosteroids, digoxin thiazide, diuretics, and supplements 30 days before study.
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Gharbyea, Egypt
Patients applied
Trial Officials
Eman B Elsaadany
Principal Investigator
Pediatric medicine Department, Faculty of Medicine, Tanta University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported